Wetherby Asset Management Inc
- SEC CIK
- 0001279627
- Latest filing
- Nov 14, 2025
RARE holding history
Ultragenyx Pharmaceutical Inc. in every 13F filed by Wetherby Asset Management Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RARE overviewAll 13F holders of RAREFull Q3 2025 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −5,081−100.0% | Sold out | Holders |
| Q1 2022 | 5,081 | $369.0K | <0.1% | +125+2.5% | Added | Holders |
| Q4 2021 | 4,956 | $417.0K | <0.1% | +204+4.3% | Added | Holders |
| Q3 2021 | 4,752 | $429.0K | <0.1% | −5−0.1% | Reduced | Holders |
| Q2 2021 | 4,757 | $454.0K | <0.1% | +4,757 | New | Holders |